Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-24 @ 6:33 PM
NCT ID:
NCT01572857
Eligibility Criteria:
Inclusion Criteria:
* For the first part of the study :
* adult patient
* giving a free, informed and written consent
* patient having a follow-up in the service for multiple myeloma, whatever the age of diagnosis, the isotype of monoclonal component, stage and disease activity
* patient hospitalized in the service whatever the reason for hospitalization (related or not with multiple myeloma)
* proteinuria ≥ 500 mg/24h
* percentage of albuminuria \< 50% on urinary protein electrophoresis
* presence of immunoglobulin FLC in immunofixation of urine proteins
* For the second part of the study :
* adult patient
* giving a free, informed and written consent
* patient having a follow-up in the service for multiple myeloma, whatever the age of diagnosis, the isotype of monoclonal component
* requiring the initiation of treatment with chemotherapy
* proteinuria ≥ 500 mg/24h
* percentage of albuminuria \< 50% on urinary protein electrophoresis
* presence of immunoglobulin FLC in urine proteins immunofixation
Exclusion Criteria:
* minor patient
* proteinuria \< 500 mg/24h
* predominantly glomerular proteinuria with ≥ 50% albumin on urinary protein electrophoresis
* absence of immunoglobulin FLC in urine proteins immunofixation
* progressive urinary infection
* patient with a glomerular nephropathy
* macroscopic hematuria
* patient unable to perform a urinary collection for 24 hours
* patient unable to give a consent
* pregnant or lactating woman
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01572857
Study Brief:
Protocol Section:
NCT01572857